4.6 Review

Promising nanomaterials in the fight against malaria

Journal

JOURNAL OF MATERIALS CHEMISTRY B
Volume 8, Issue 41, Pages 9428-9448

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d0tb01398f

Keywords

-

Funding

  1. Ministerio de Ciencia, Innovacion y Universidades, Spain, FEDER funds [RTI2018-094579-B-I00, PCIN-2017-100, PGC2018-097583-B-I00, PGC2018-093761-B-C31, CTQ2017-90596-REDT]
  2. ERA-NET Cofund EURONANOMED [2017-178]
  3. Generalitat de Catalunya, Spain [2017-SGR-908]
  4. Gobierno de Aragon-FSE [E47_20R]
  5. Spanish Ministry of Science, Innovation and Universities through the Centro de Excelencia Severo Ochoa 2019-2023 Program [CEX2018-000806-S]
  6. Fundacion Ramon Areces
  7. European Commission under Horizon 2020's Marie Skodowska-Curie Actions COFUND scheme [712754]
  8. Severo Ochoa programme of the Spanish Ministry of Science and Competitiveness [SEV-2014-0425]
  9. Ministerio de Ciencia, Innovacion y Universidades [BES-2016-078774]

Ask authors/readers for more resources

For more than one hundred years, several treatments against malaria have been proposed but they have systematically failed, mainly due to the occurrence of drug resistance in part resulting from the exposure of the parasite to low drug doses. Several factors are behind this problem, including (i) the formidable barrier imposed by the Plasmodium life cycle with intracellular localization of parasites in hepatocytes and red blood cells, (ii) the adverse fluidic conditions encountered in the blood circulation that affect the interaction of molecular components with target cells, and (iii) the unfavorable physicochemical characteristics of most antimalarial drugs, which have an amphiphilic character and can be widely distributed into body tissues after administration and rapidly metabolized in the liver. To surpass these drawbacks, rather than focusing all efforts on discovering new drugs whose efficacy is quickly decreased by the parasite's evolution of resistance, the development of effective drug delivery carriers is a promising strategy. Nanomaterials have been investigated for their capacity to effectively deliver antimalarial drugs at local doses sufficiently high to kill the parasites and avoid drug resistance evolution, while maintaining a low overall dose to prevent undesirable toxic side effects. In recent years, several nanostructured systems such as liposomes, polymeric nanoparticles or dendrimers have been shown to be capable of improving the efficacy of antimalarial therapies. In this respect, nanomaterials are a promising drug delivery vehicle and can be used in therapeutic strategies designed to fight the parasite both in humans and in the mosquito vector of the disease. The chemical analyses of these nanomaterials are essential for the proposal and development of effective anti-malaria therapies. This review is intended to analyze the application of nanomaterials to improve the drug efficacy on different stages of the malaria parasites in both the human and mosquito hosts.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available